RIGEL PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $208.3M | $20.9M |
| FY2014 | — | $128.2M | $15.2M |
| FY2015 | — | $91.4M | $43.5M |
| FY2016 | — | $55.0M | $17.6M |
| FY2017 | — | $100.6M | $38.3M |
| FY2018 | — | $109.9M | $76.3M |
| FY2019 | $10.0M | $53.8M | $22.5M |
| FY2020 | $20.0M | $34.0M | $30.4M |
| FY2021 | $20.0M | $30.4M | $18.9M |
| FY2022 | $40.0M | $-13.6M | $24.5M |